Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Pol

Showing results (131-140 of 441) with videos related to

Pageof 45
Sort By:
Virology|August 2, 2005
The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patientsGeneviève Janvier, Marie Laure Chaix, Hélène Fontaine, et al.
La Revue Du Praticien|April 2, 2011
[Treatment of hepatitis C]Marc Bourlière, Asma Khaloun, Paul Castellani, et al.
Journal of Hepatology|October 20, 2007
Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006Patrice Cacoub, Philippe Halfon, Eric Rosenthal, et al.
Psychiatry Research|June 23, 2024
Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims databaseBenjamin Rolland, Nabil Hallouche, Olivier Lada, et al.
European Radiology|September 17, 2015
Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imagingHervé Gouya, Sophie Grabar, Olivier Vignaux, et al.
Hepatology (Baltimore, Md.)|July 27, 2002
NNRTI-related or -unrelated hepatotoxicity?Pascal Lebray, Yves Benhamou, Stanislas Pol, et al.
Antiviral Therapy|October 9, 2009
Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 StudyPatrice Cacoub, Fabrice Carrat, Pierre Bédossa, et al.
European Journal of Gastroenterology & Hepatology|June 8, 2015
Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?Maud Pacou, Federica Basso, Charles Gore, et al.
Gastroenterologie Clinique Et Biologique|October 30, 2007
[Management of HCV-HIV patients]Stanislas Pol, Patrice Cacoub, Gilles Pialoux, et al.
Annals of Internal Medicine|September 17, 2008
Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis CVincent Mallet, Hélène Gilgenkrantz, Jeanne Serpaggi, et al.
Pageof 45

Showing results (131-140 of 441) with videos related to

Sort By:
Pageof 45
Virology|August 2, 2005
The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patientsGeneviève Janvier, Marie Laure Chaix, Hélène Fontaine, et al.
La Revue Du Praticien|April 2, 2011
[Treatment of hepatitis C]Marc Bourlière, Asma Khaloun, Paul Castellani, et al.
Journal of Hepatology|October 20, 2007
Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006Patrice Cacoub, Philippe Halfon, Eric Rosenthal, et al.
Psychiatry Research|June 23, 2024
Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims databaseBenjamin Rolland, Nabil Hallouche, Olivier Lada, et al.
European Radiology|September 17, 2015
Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imagingHervé Gouya, Sophie Grabar, Olivier Vignaux, et al.
Hepatology (Baltimore, Md.)|July 27, 2002
NNRTI-related or -unrelated hepatotoxicity?Pascal Lebray, Yves Benhamou, Stanislas Pol, et al.
Antiviral Therapy|October 9, 2009
Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 StudyPatrice Cacoub, Fabrice Carrat, Pierre Bédossa, et al.
European Journal of Gastroenterology & Hepatology|June 8, 2015
Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?Maud Pacou, Federica Basso, Charles Gore, et al.
Gastroenterologie Clinique Et Biologique|October 30, 2007
[Management of HCV-HIV patients]Stanislas Pol, Patrice Cacoub, Gilles Pialoux, et al.
Annals of Internal Medicine|September 17, 2008
Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis CVincent Mallet, Hélène Gilgenkrantz, Jeanne Serpaggi, et al.
Pageof 45